Methods: A total of 140 community-dwelling individuals with SMI completed an anonymous self-report questionnaire consisting of questions for background information and the original 27-item SESP on a 4-Likart scale. The first data analysis was an exploratory factor analysis (principal component method with varimax rotation). Then we mainly chose ten items which were big factor loading in the factor structure of the 27-item SESP. We assumed them the short version of SESP (SESP10). And we performed confirmatory factor analysis to inspect the factorial validity of SESP10. Results: From results of confirmatory factor analysis, SESP10 was kept structure of 4 interpretable factors: Trust for Social Self, Self Management, Social Adaptability, and Mutual Support. It became clear that SESP10 had enough constructive validity. In addition, Internal consistency of the total SESP10 was excellent (α=.91). Discussion: It was proved that SESP10 had a sufficient validity. It will be to review the predictive and criterion-related validity of SESP10 in future. The short version of the Self-Efficacy for Social Participation for People with Psychiatric Disabilities scale has potential as a reliable and valid scale for measurement of self-efficacy of people who are afflicted with severe mental illnesses and who live in the community. Fibromyalgia syndrome (FMS) is a disease of unknown pathogenesis characterized by chronic musculoskeletal pain. FMS also includes other symptoms like poor quality sleep, morning stiffness, fatigue, anxiety, depression and altered endocrinological responses, but findings are inconsistent. The aim of the present study was to investigate free salivary cortisol levels, urinary catecholamines (noradrenaline, adrenaline and dopamine), heart rate, self-reported pain, and psychological features in FMS patients compared with healthy controls. Twenty-nine female FMS patients and 29 age-matched healthy female controls were recruited. Questionnaires measuring pain levels, sleeping problems, perceived stress and personality were administered to the participants. Salivary cortisol samples were collected 8 times: in the afternoon when subjects arrived at the hospital, after stress provocation, in the evening, before they went to sleep, upon awakening, 30 and 60 minutes later, and during the afternoon of the second day. Urinary catecholamines were repeatedly measured from the corresponding 24-hours period. Results revealed significantly more pain, perceived stress, sleeping problems, anxiety and depression among FMS patients compared with controls. Patients with FMS had significantly lower cortisol levels during the day, most pronounced in the morning (Cortisol Awakening Response). Moreover, FMS patients had significant lower adrenaline and dopamine levels compared with healthy controls, but similar noradrenaline levels. Furthermore, FMS patients showed increased heart rate values and lower sleep quality. Results support the hypothesis of a dysfunction in the regulation of the stress systems in FMS patients, and increased pain perception and sleeping problems. Emerging evidence suggests that immersive Virtual Reality (VR) distraction is an efficacious intervention for procedural pain. VR distraction offers an alternative to pharmacological treatments that may cause adverse side effects. Although VR distraction has been demonstrated to be effective in laboratory and clinical settings, the method by which it works to combat pain remains unclear. McCaul and Malott (1984) hypothesize that pain processing requires conscious attention. A highly immersive distractor should leave less attention available for pain processing. This study examined whether a VR head-mounted display helmet increases the analgesic effects of interactive distraction. A head-mounted display occludes extraneous sights and sounds, helping a person feel 'present' in the virtual world, leaving less attention available for pain sensations originating outside of the virtual world. Seventy-three college students between the ages of 18 and 25 were exposed to cold pressor pain without any distraction intervention (baseline) and then two cold pressor trials during which they played a Nintendo® Wii videogame. They viewed the game on a 21" TV or through a VR head-mounted display unit. The study used a within-subjects repeated-measures design, with the two videogame distraction trials presented in counterbalanced order following baseline. LOG-10 transformation was conduced on all pain tolerance scores to correct for skew and kurtosis. Results showed that pain tolerance during the baseline trial (M=1.46, SD=.254) was significantly lower than pain tolerance during the helmet-on condition (M=1.72, SD=.329), t(72) = -11.24, p<.001, and the helmet-off condition (M=1.68, SD=.32), t(72) = -10.69, p<.001. Participants showed the greatest increases in pain tolerance in the helmet-on condition, t(72) = 2.82, p<.01. Further research is needed to determine whether these results could be replicated in a clinical setting. Persistent pain, sufficient to cause significant impairment in daily functioning affects up to 50 percent of older adults. Analgesics are the most common therapy used to manage pain, with opioids playing an increasingly important role in pharmacological treatment of chronic disabling pain in older adults. The efficacy of medication therapy needs to be balanced against potential side effects, including the risk of neurocognitive impairment. In this study we objectively examined neurocognitive effects of methadone in older adults (>65 years) suffering from daily chronic pain (osteo-arthritis). Older participants (mean age 76 years) were evaluated twice at baseline (prior to the start of medication) and again 24hours after initial dose and again after 5 and 21 days of medication. Subjective ratings of pain along with objective testing of memory, attention and concentration were measured. Physiologic measurement of medication effects (pupil size) were also obtained. Results indicate a slight decline in weekly pain ratings (NS) and a modest drop in pupil size (NS). Neurocognitive tests indicated no significant change from baseline on measures of memory (HVLT), concentration (D2), reaction time or global cognitive measures (MMSE). There was an improvement on a measure of working memory (p<.05) and a trend toward improvement on an attention task (p<.06). Global measures of functioning did not change. Taken together, results suggest that older adults suffering from chronic non-malignant pain do not experience significant decrements in cognitive functioning in response to methadone. This may be consistent with findings of improved cognition with improved pain control observed in younger samples. Aim of investigation: There is limited knowledge about vulnerability factors for pain in fibromyalgia (FM), but low education, hereditary influences and mood are known, while contextual triggers and personality factors are dubious. Our aim was to study how FM pain differed in two contexts. Methods: Fiftyfive female FM patients scored pain (VAS 0-100), demographic data (age, education, and single status), mood (depression/BDI and anxiety/STAI-T), Cluster C personality traits (avoidance, OCD, dependence by MCMI-I), sleep (VAS), TCA-use dummy and FM-duration. Main outcome was Pain-difference (VAS) between "pain measured in a doctor's office" and "pain measured alone at home" one hour later. Secondary outcomes were vulnerability and resilience factors for pain in those two contexts. Results: "Pain office" (VAS=50.6) versus "Pain home" (VAS=43.4) showed a significant difference=7.2 by a paired t-test [t = 2.4; df=54; p=0.022]. Generalized Linear Methods (GLM) formula end-model: "Pain office" ∼ Anxiety + Education showed that Anxiety (t=3.15, p<0.01) facilitated the "pain office" experience, while Education (t=−2.43, p<0.05) impeded it. Avoidance (t=2.66, p=0.01) and "poor sleep" (t=2.55, p<0.05) worsened the "home-context pain". Conclusions: Pain was perceived weaker at home than in the doctor-office. Avoidance and poor sleep were vulnerability factors for pain at home, while trait-anxiety worsened pain in the office. Education was a resilience factor against pain in the doctor-office, while no resilience factors were found at home except the home context itself. Symptoms of Irritable bowel syndrome (IBS) are often aggravated by stress, which alters colonic motility and visceral perception. We reported the possibility of improving IBS pathophysiology by passive abdominal muscle stretching as indicated by chromogranin A (CgA), a biochemical index of the activity of the sympathetic / adrenomedullary system. Although the degree to which patient intervention in the areas of exercise, and management of daily activity can improve symptoms of IBS through healthier lifestyle behaviors is unknown. Int.J. Behav. Med. (2010) 17 (Suppl 1):S1-S329 S157